Clinical Trials Browser

Terminated × INDUSTRY × Lymphoma, Extranodal NK-T-Cell × Clear all

NCT04425070 2026-01-05

TOUCH

Phase 1/2 Terminated

Lymphoma, T-Cell, Peripheral, Lymphoma, Extranodal NK-T-Cell

NCT04509466 2024-03-07

Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCL

Phase 1/2 Terminated

Lymphoma, Extranodal NK-T-Cell

NCT04602065 2023-03-15

Evaluation of Safety and Efficacy of IBI318 Monotherapy for Relapsed/Refractory Extranodal NK/T Cell Lymphoma (Nasal Type) Trial

Phase 1/2 Terminated

Lymphoma, Extranodal NK-T-Cell

NCT01948180 2019-03-13

CITADEL

Phase 2 Terminated

Epstein-Barr Virus Infections, Lymphoma, Extranodal NK-T-Cell